The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Are crop innovations sitting on shelf because of outdated GMO laws?

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

Getting a new genetically modified plant to farms takes years of field trials and repetitive studies. The process is often too time-consuming and expensive for the public sector or for small startups. If seed companies don’t see dollar signs. . . new technology can wither away.

. . . .

That’s one complaint about existing federal oversight of biotechnology: the time and money it takes to bring new products to the public are stifling innovation.

But there are other problems. . . . today a wave of new discoveries is breaking out of [the] old regulatory framework. Inventions like gene editing and programmable cells could transform everything from agriculture and medicine to energy and manufacturing.

“How we make things is going to change in an absolutely fundamental way,” says biotech investor Juan Enriquez. . . .

Last year the White House told the three federal agencies to update the regulatory system and open a simpler path for new biotechnology. . . . Enriquez says regulators have a tough challenge.

“You have to have what is almost impossible to have in today’s political climate which is a nuanced debate,” he says.

Read full, original post: New genetically modified crops push old regulations

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend